Report Overview
Brachytherapy is a form of internal radiation therapy where radioactive sources are placed directly inside or near a tumor, delivering high doses of radiation with minimal impact on surrounding healthy tissues. It is commonly used to treat cancers such as prostate, cervical, breast, and skin cancers among others. Brachytherapy can be administered in different modalities, including low-dose rate (LDR) and high-dose rate (HDR) techniques. This targeted approach allows for shorter treatment durations, fewer side effects, and improved patient outcomes. Advancements in imaging and AI-driven planning have further enhanced its precision, making it an increasingly important component of modern cancer treatment.

To learn more about this report, download the PDF brochure
Rising global cancer burden to propel market demand
The rising global cancer burden is a major driver of the brachytherapy market, as increasing cancer incidence boosts demand for effective, targeted treatments. Prostate, cervical, and breast cancers, which are the key indications for brachytherapy, are becoming more prevalent due to aging populations, lifestyle factors, and environmental risks. Brachytherapy-s ability to deliver high radiation doses with minimal healthy tissue damage makes it a preferred option for many patients. Additionally, healthcare systems worldwide are expanding oncology infrastructure, increasing investment in radiation therapy, and improving access to advanced treatments, further fueling the adoption of brachytherapy as a crucial component of cancer care.
Clinical benefits and minimally invasive nature of brachytherapy are driving the market growth

To learn more about this report, download the PDF brochure
Competitive Landscape Analysis
The global brachytherapy market is marked by the presence of established and emerging market players such as Elekta; Varian Medical Systems (A Siemens Healthineers Company); Theragenics Corporation; Becton, Dickinson and Company (BD); Eckert & Ziegler; Ariane Medical Systems Ltd; CIVCO Medical Solutions; Sun Nuclear Corporation; IsoAid, LLC; and Best Medical International, Inc.; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.
Report Scope
|
Report Metric |
Details |
|
Base Year Considered |
2024 |
|
Historical Data |
2023 - 2024 |
|
2025 - 2030 |
|
|
7% |
|
|
Market Drivers |
|
|
Attractive Opportunities |
|
|
Segment Scope |
Dosage Type, Product, Application, End User |
|
Regional Scope |
|
|
Key Companies Mapped |
Elekta; Varian Medical Systems (A Siemens Healthineers Company); Theragenics Corporation; Becton, Dickinson and Company (BD); Eckert & Ziegler; Ariane Medical Systems Ltd; CIVCO Medical Solutions; Sun Nuclear Corporation; IsoAid, LLC; and Best Medical International, Inc.; among others |
|
Report Highlights |
Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Global Brachytherapy Market Segmentation
This report by Medi-Tech Insights provides thesize of the global brachytherapy market at theregional- and country-level from 2023 to 2030. The report further segments the market based on dosage type, product, application, end user.
Market Size & Forecast (2023-2030), By Dosage Type, USD Million
- High-Dose Rate (HDR)
- Low-Dose Rate (LDR)
Market Size & Forecast (2023-2030), By Product, USD Million
- Afterloaders
- Seeds
- Applicators & Needles
- Electronic Brachytherapy Systems
Market Size & Forecast (2023-2030), By Application, USD Million
- Prostate Cancer
- Cervical Cancer
- Breast Cancer
- Others
Market Size & Forecast (2023-2030 USD Million
- Hospitals
- Specialty Clinics & Cancer Treatment Centers
- Ambulatory Surgical Centers (ASCs)
- Others
Market Size & Forecast (2023-2030), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Key Strategic Questions Addressed
- What is the market size & forecast of the brachytherapy market?
- What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the brachytherapy market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players operating in the market?
- What are the key strategies adopted by players?
Need a More Tailored Analysis?
- Discuss the market sizing methodology and forecast assumptions with our healthcare analysts.
- Expand the scope with additional countries, market segments, technologies, or competitor profiling.
- Use the insights to support strategic planning, market entry, commercial due diligence, and long-term revenue growth initiatives.